Rapid Diagnostics


News & Events


September 2017

from Sept 13th to 15th the BBTS Annual Conference is taking place in Glasgow


Davos Diagnostics is presenting the new EVA Reader R6 and the Platelets Typing Assays for HPA-1a and HPA-5b on a booth in the exibition


September 2017

from Sept 20th to 22th the EFSAnnual Conference is taking place in Bordeaux, France


Davos Diagnostics is presenting the new EVA Reader R6 and the Platelets Typing Assays for HPA-1a and HPA-5b on a booth in the exibition


April 2017

the first HPA-1A typing assay kit for research use are ready to be tested on the Reader R6:





March 2017

the new ISO-certificate is mounted:



February 2017 

Davos Diagnostics awarded with SLAS Innnovation AveNEW at SLAS2017 in Washington 

SLAS Innovation AveNEW is a special section of the SLAS2017 Exhibition which showcases a collection of new and emerging companies that offer especially creative technologies especially geared toward the life science research and development market. Every year, companies from around the world vie for positions on SLAS Innovation AveNEW. Those selected by an independent judging committee of SLAS volunteers receive complimentary exhibit space and amenities, travel and lodging for one company representative, and considerable promotional visibility at the flagship annual SLAS conference and exhibition. 

You are invited to join Davos Diagnostics at SLAS2017 in Washington, where we will be showcasing our latest offerings and technologies, and will have our top product experts on hand to answer your questions. We are looking forward seeing you in Washington at booth 1637. 


November 2016 


Davos Diagnostics AG at the biggest medical fare. Medica took place from 13.-16 November in Düsseldorf, Germany. The booth of DDX generated a lot of interest and the feedback of the technology was very positive.

We showed the new Reader R6 and the completly new developed User interface for easy handling.





November 2016 

The European Patent Office grants Davos Diagnostics the EP 2 796 880 titled Platelet allo-antigen typing and platelet antibody tests.  

Human Platelets, also called thrombocytes, are one of the principal blood products that find application in the treatment of thrombocytopenic patients i.e. patients with low platelet numbers and a tendency to bleed. There are different allelic forms of the platelet glycoproteins characterised by single amino acid changes. Transfusing non-compatible platelet concentrates can lead to allo-immunisation against platelets receiving a non-matched platelet concentrate.   

Davos Diagnostics has developed one-step  antigen typing tests to identify carriers of the two clinically most immunogenic Human Platelet Allo-Antigens HPA-1a and HPA-5b. The assay uses the Davos Diagnostics evanescence biosensor technology and allows platelet antigen determination in a blood sample in just ten minutes. Using antigen matched platelets will improve the safety and efficacy of platelet transfusions and enables a responsible use of the precious platelet donations from human blood donors.  

For further information and the full patent see the EPO online at https://worldwide.espacenet.com/advancedSearch


Oktober 2016

We are hiring  people: 

If you are interested to work with us at Davos Diagnostics...have a look 



August 2016

The EVA Reader R6 is born. The first assembled Readers are awaiting the marriage with the software developed by our partners.


February 2016

Evaluation Partners of Davos Diagnostics are presenting results of the HPA-1a typing test on GTH Congress 2016, Münster Germany. Prof Bugert and co-workers are presenting the abstract "EVALUATION OF THE EVANESCENT BIOSENSOR TECHNOLOGY FOR RAPID PHENOTYPING OF THE HUMAN PLATELET ALLOANTIGEN 1A" 380 blood donors were 100% correctly typed with the Davos Diagnostics HPA-1a typing assay.


January 2015

Davos Diagnostics AG exhibits at the World Immune Regulation Meeting (WIRM) 2015

Davos Diagnostics AG will have a booth at the upcoming 9th World Immune Regulation Meeting (WIRM) held from 18 - 21 March 2015 in the Davos Congress Center. Please come to visit us and learn more about our innovative EVA-Technology. 

More info about WIRM - click here.


December 2014

Davos Diagnostics AG accomplishes ISO 13485 certification

Davos Diagnostics AG, a medical diagnostics company and a specialist in the development and manufacture of rapid in-vitro diagnostic tests, has been successfully certified according to ISO13485:2012, the international standard for quality management systems for medical devices. The ISO 13485 certification validates Davos Diagnostics' quality system and confirms Davos Diagnostics' commitment to medical technology and its stringent demands in fulfilling customer and regulatory requirements.

Davos Diagnostics was audited by TÜV Austria, an internationally recognized testing body that has been assessed and accredited by numerous accreditation bodies.